Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) CFO Tighe Reardon sold 822,721 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $54.75, for a total value of $45,043,974.75. Following the sale, the chief financial officer now directly owns 633,673 shares of […]
Avalon Makes Pure Play With Bio-Only VC Firm - San Diego Business Journal sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.